Bristol-Myers Squibb Cash Flow Statement
View: Annual | Quarterly
| Quarter Ending Jun 08 |
Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
|
|---|---|---|---|---|---|
| Net Operating Cash Flow | 1,140.0 | 779.0 | 630.0 | 697.0 | 1,061.0 |
| Net Investing Cash Flow | (526.0) | 572.0 | 34.0 | 394.0 | (637.0) |
| Net Financing Cash Flow | 988.0 | (734.0) | (524.0) | (1,844.0) | (264.0) |
| Net Change in Cash | 1,604.0 | 642.0 | 154.0 | (732.0) | 165.0 |
| Depreciation & Amortization | 203.0 | 251.0 | 254.0 | 213.0 | 209.0 |
| Capital Expenditures | (210.0) | (250.0) | (250.0) | (185.0) | (206.0) |
| Cash Dividends Paid | (617.0) | (613.0) | (554.0) | (556.0) | (552.0) |






